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Abstract
A new model of atherosclerosis cell membrane chromatography has been established by
using a CD40 cell membrane stationary phase (CD40 CMSP) prepared by immobilizing the
CD40 cell membrane onto the surface of a silica carrier. The surface and chromatographic
characteristics of CD40 CMSP were studied. The retention characteristics of anti-CD40
antibody and statins (lovastatin, simvastatin and pravastatin) were also investigated using this
model. Affinities of the anti-CD40 antibody and statins toward CD40 cell membrane and
receptors were based on the determination of log k0 values (the logarithm of capacity factor
of a solute). There was a significant correlation between the affinity in the CD40–CMC and






CD40 is a 50 kDa integral membrane
protein of the tumor necrosis factor
(TNF) receptor family. Expression of
CD40 has been documented for a variety
of non-immune cells including endothe-
lial cells, ﬁbroblasts and vascular smooth
muscle cells. CD40L (39 kDa) serves as
the ligand for CD40 and is also a mem-
brane-bound member of the TNF gene
family that is expressed by T-cells and
activated platelets [1]. The CD40–
CD40L system is proven to be an
important mediator of several auto-im-
mune and chronic inﬂammation diseases
[2]. Interruption of CD40–CD40L sig-
naling not only reduces the initiation and
progression of atherosclerotic lesions in
vivo [3, 4] but also impacts on plaque
architecture [5, 6]. Moreover, it has been
reported that CD40–CD40L serves as a
key regulator of this process which may
render this therapeutically useful for the
treatment of atherosclerotic conditions
[4].
The purpose of the present work was
to develop a new model of CD40 cell
membrane chromatography (CD40–
CMC) using anti-CD40 antibody and
statin derivatives (lovastatin, simvastatin
and pravastatin) as model molecules.
Experimental
Instruments
The chromatographic system consisted
of a LC-10ATvp chromatographic
pump, a SPD-10Avp detector (Shima-
dzu, Japan), a 7725i hand sampling valve
(Rheodyne, USA), and a LC-Solution
chromatographic work station (Shima-
dzu, Japan).
Materials and Reagents
Macroporous silica (3–5 lm, 100 A˚)
(Institute of Chemistry of the Chinese
Academy of Sciences, China) were used.
An endothelial cell line derived from
human umbilical vein endothelial cells
(HUVEC) was purchased from the
Shanghai Institute of Cell Biology in the
Chinese Academy of Sciences (Shanghai,
China). Fetal bovine serum was pur-
chased from Hangzhou Sijiqing Serum
Works. RPMI1640 and trypsin were
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purchased from Sigma (USA). Lova-
statin, simvastatin and pravastatin were
purchased from Sigma (St Louis, MO,
USA). Anti-CD40 antibodies were pur-
chased from Santa Cruz Biotechnology
(St Cruz, CA, USA). Dibasic sodium
phosphate, sodium chloride, potassium
chloride, hydrochloric acid and phos-
phoric acid were of analytical grade.
Deionized water was of HPLC grade.
Salvia miltiorrhiza was identiﬁed by the
Pharmacognostical Lab from the
College of Pharmacy, Xi’an Jiaotong
University.
Establishment of the Model
of CD40 CMC
Cell Culture
HUVEC overexpressing CD40 was cul-
tured in monolayer in RPMI1640 sup-
plemented with 10% fetal bovine serum
and propagated for several days in a
humidiﬁed incubator at 37 C and 5%
CO2 [7, 8]. Native HUVEC was cultured
under similar conditions as a minus
control. The extent of CD40 protein
expression in both HUVEC and native
HUVEC was determined by Becton
Dickinson FACScan ﬂow cytometry
using CellQuest software (Becton
Dickinson).
Preparation and Chromatographic
Characteristics of CD40 CMSP
After HUVEC high throughput expres-
sion, CD40 cells were cultured until 80%
conﬂuent, digested with 0.25% trypsin
and centrifuged at 1,000g for 10 min.
The precipitate was resuspended in
deionized water and left for 30 min,
sonicated for 10 min and centrifuged at
2,000g for 20 min. The supernatant was
centrifuged at 12,000g for 20 min. All
procedures were performed at 4 C [9].
The protein level, K+–Na+–ATP enzy-
matic activity of the cell membrane have
also been determined. The membrane
protein level was 2.14 mg mL1. The
CD40 cell membranes were stored at
34 C.
Three hundred mg activated silica
was added to a 10 mL reaction tube and
then the CD40 cell membrane suspen-
sion was slowly added under the evacu-
ation condition at 4 C. The adsorption
of the cell membranes on the activated
silica surface was carried out for 1 h
until equilibrium. Then, the supernatant
in the tube was removed by centrifuga-
tion and the CD40 CMSP was washed
with Tris–HCl buﬀer until there was no
residual free cell membrane present.
The surface characteristics of CD40
CMSP were analyzed by a scanning
electron microscope and a surface energy
spectrometer.
Chromatographic Conditions
The CD40 CMSP was dispersed in a
buﬀer and packed as a slurry under low
pressure (30 mm · 2 mm column). The
ﬂow rate of the mobile phase
(50 mmol L1 phosphate buﬀer solution
at pH 7.4) was set to 0.5 mL min1 at
37 C. The detection wavelength was
254 nm. Before injection the chromato-
graphic system required around 3–4 h in
order to establish equilibrium. Five
microliters anti-CD40 antibodies and
statins (lovastatin, simvastatin and




The expression of CD40 protein in the
transfected HUVEC and native HUVEC
was detected by Becton Dickinson
FACScan ﬂow cytometry using Cell-
Quest software (Becton Dickinson). The
result showed that both transfected
HUVEC and native HUVEC expressed
CD40 protein, and the expression of
CD40 in the transfected HUVEC was
91.2 ± 8.7%, which was much higher
than that in native HUVEC
(23.6 ± 2.6%). The result indicated that
the transfected HUVEC highly expresses
CD40 protein, which is applied to
improvement of the speciﬁcity and
selectivity of CMC model.
The Surface Characteristic
of CD40 CMSP
The surface energy spectrum of the silica
carrier revealed the presence of a low
peak of oxygen and a high peak of silica.
In case of the CD40 CMSP, not only a
new carbon peak was detected but also
the silica peak almost disappeared. This
indicated that the surface of silica carrier
was completely covered by the cell
membranes.
Retention Behavior
of Reagents in CD40–CMC
The chromatographic column packed
with the CD40 CMSP did not only
maintain the enzymatic activity but also
showed bio-aﬃnity. The column system
was able to selectively recognize the drug
molecule or ingredient acting on the
CD40 cell membrane. As is the case with
other chromatographic methods, the
aﬃnity of the solute can be expressed by
using the log capacity factor (log k0):
log k0 ¼ log tR  t0ð Þ=t0½ 
where tR is the retention time of solute,
t0 the elution time of a non-retentive
solvent.
Table 1 shows a comparison of
retention characteristics between anti-
CD40 antibodies and a selection of
statins (lovastatin, simvastatin and
pravastatin). It can bee seen that chro-
matographic retention was observed
when the CD40 CMSP system was used
but not when only pure silica was pres-
ent which indicated antibody–receptor
aﬃnity.
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Correlation
with Pharmacological Activity
The CD40 expression in the transfected
HUVEC was 91.2 ± 8.7% without drug
interfere. Flow cytometry analysis
revealed that the presence of antibodies
and three statins reduced CD40 expres-
sion in the transfected HUVEC cell line
after a 24 h preincubation period. Inhi-
bition occurred in the following order:
antibody (63%) > lovastatin (54%) >
simvastatin (43%) > pravastatin (28%).
This order had a very close correlation
with the log k0 value obtained from the
CD40–CMC system (r2 = 0.9954).
The results indicated that there was a
signiﬁcant correlation between the aﬃn-
ity in the CD40–CMC and the eﬀect in
vitro for the pharmacological eﬀect. The
stable highly expression of CD40 CMC
was prepared to screen the eﬀective anti-
atherosclerostic components of Salvia
miltiorrhiza [10].
Conclusions
The model of CD40 cell membrane
chromatography was established using
cell membrane of CD40 cell cultured in
vitro.
The in vivo interaction between stat-
ins and the CD40 cell membrane recep-
tor can be quantitatively assessed by
using the CD40 CMC system in vitro.
The log k0 aﬃnity parameter obtained by
the system showed a signiﬁcant correla-
tion with drug eﬀects.
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